Executive Chairman of the Board

Mr. Kevin Giese was the founder of BioMS Medical Corp. which company raised over $280 million, and in 2008 was designated Biotech Company of the year in Canada and awarded the Scrips Award for Best International Licensing Deal.

Mr. Giese has been on the board of directors of a number of private and publicly listed companies, including Spectral Diagnostics Inc. since March 2010, and Mimetogen Pharmaceuticals Inc. since October 2011.

He has been a member of the board of directors of BioAlberta, an advisory member of the Institute of Corporate Directors (Canada) and has received awards for entrepreneurship from BioAlberta and Ernst & Young. Mr. Giese has a B.A., a law degree and an M.B.A.

Dr. Brazzell has served as our Chief Medical Officer from January 2012 to December 2015.. Dr. Brazzell also held several executive positions at Inspire Pharmaceuticals, Inc., or Inspire, a specialty pharmaceutical company focusing on ophthalmic products, including Executive Vice President of Medical and Scientific Affairs from 2010 to 2011, Executive Vice President and Head of Ophthalmology Business from 2009 to 2010, and Senior Vice President of Ophthalmic Research and Development from 2004 to 2008.


Prior to joining Inspire, Dr. Brazzell served as Global Head of Clinical R&D and Senior Vice President, U.S. R&D, of Novartis Ophthalmics AG from 2000 to 2004. Dr. Brazzell also served as Vice President, R&D at Ciba Vision Ophthalmics, Inc. and as Associate Director, R&D, at Alcon Laboratories, Inc. Dr. Brazzell received a B.S. in Pharmacy and a PhD in Pharmaceutical Sciences from the University of Kentucky.

Chief Executive and Financial Officer